Table 1 Baseline characteristics
From: Ethnicity and thrombolysis in ischemic stroke: a hospital based study in Amsterdam
| Â | White (n = 392) | Non-white (n = 118) | P-value |
|---|---|---|---|
Ethnicity | Â | Â | Â |
Black | - | 53% | Â |
Asian | - | 37% | Â |
Turkish | - | 3% | Â |
Moroccan | - | 1% | Â |
Other | - | 6% | Â |
Patient characteristics | Â | Â | Â |
Gender (% female) | 45% | 54% | 0.08 |
Age | 69 (59-79) | 60 (49-72) | < 0.001 |
BMI | 25 (23-27) | 27 (24-31) | 0.03 |
Systolic blood pressure | 150 (135-176) | 160 (140-186) | 0.02 |
Diastolic blood pressure | 82 (75-95) | 90 (80-100) | 0.003 |
NIHSS | 5 (2-12) | 4 (2-6) | 0.04 |
TOAST classification | Â | Â | Â |
Small-vessel disease | 36% | 59% | < 0.001 |
Large-vessel disease | 40% | 25% | Â |
Cardioembolic stroke | 15% | 8% | Â |
Other known cause | 4% | 4% | Â |
Undetermined cause | 6% | 5% | Â |
Baseline medication use | Â | Â | Â |
Platelet inhibitors | Â | Â | Â |
   Aspirin | 19% | 10% | 0.02 |
   Dipyridamole | 5% | 5% | 0.99 |
   Clopidogrel | 2% | 1% | 0.32 |
Oral anticoagulation | 14% | 6% | 0.02 |
Antihypertensive | 49% | 43% | 0.27 |
Antihyperlipidemic | 26% | 18% | 0.08 |
Antidiabetic | 15% | 29% | < 0.001 |
Cardiovascular risk factors | Â | Â | Â |
Hypertension | 55% | 62% | 0.21 |
Untreated hypertension | 23% | 32% | 0.15 |
Diabetes | 18% | 39% | < 0.001 |
Hypercholesterolemia | 29% | 34% | 0.37 |
Smoking (previous or current) | 64% | 47% | 0.003 |
Atrial fibrillation | 14% | 9% | 0.11 |
Previous stroke | 23% | 20% | 0.55 |